Skip to main content

Richard Goldberg, MD is physician-in-chief of the N.C. Cancer Hospital and UNC Lineberger associate director of clinical research.

CHAPEL HILL, N.C. – The article “Two cancer drugs keep rare pancreatic tumors in check” written by Liz Szabo and published in the February 9, 2011 issue of USA Today cites N.C. Cancer Hospital physician-in-chief and UNC Lineberger associate director of clinical research Richard Goldberg, MD.

The article discusses two new drugs – Sutent and Afinitor – that treat a rare type of pancreatic cancer.

Read article .